Anavex Life Sciences Corp (AVXL): Guess'ers Tarot Card Readers Crys...

Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Followed By	3
Posts	521
Boards Moderated	0
Alias Born	05/31/2013

Thursday, January 27, 2022 12:39:34 PM

Re: None

Guess'ers Tarot Card Readers Crystal Ball Shiners Tea Leaves Huntches Gut Feelings The Tomorrows Next Week Next Month Next Quarter prognosticators .... Relax. Data will come soon... what it does to the SP is anyone listed aboves guess. That is how its done. It is to remain a secret until disclosed to all. It is illegal to provide blue sky where there is non. I, my friends, am going to the pool. Its 75 here to day.

Recent AVXL News

Anavex Life Sciences to Announce Fiscal 2022 Third Quarter Financial Results on Tuesday August 9, 2022 • GlobeNewswire Inc. • 08/03/2022 11:00:00 AM
Anavex Life Sciences (AVXL) Receives a Buy from BTIG • TipRanks • 08/03/2022 02:56:40 AM
Anavex Announces Long-lasting Effect of ANAVEX®3-71 Preventing Cognitive Decline in a Transgenic Rat Model of Alzheimer’s Disease at AAIC 2022 • GlobeNewswire Inc. • 08/02/2022 11:00:00 AM
H.C. Wainwright Keeps Their Buy Rating on Anavex Life Sciences (AVXL) • TipRanks • 08/02/2022 10:17:28 AM
Anavex Life Sciences (AVXL) Gets a Buy Rating from JonesTrading • TipRanks • 08/01/2022 12:55:34 PM
Anavex Announces First Entire Clinical Alzheimer’s Gene Pathway Data of ANAVEX®2-73 at AAIC 2022 • GlobeNewswire Inc. • 07/31/2022 02:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/29/2022 09:15:40 PM
Anavex Life Sciences Announces Its Very First Scientific Educational Video News Release • GlobeNewswire Inc. • 06/21/2022 12:00:00 PM
Dawson James Thinks Anavex Life Sciences’ Stock is Going to Recover • TipRanks • 06/19/2022 12:15:43 PM
Anavex’s Publication Supports Clinical Biomarker for ANAVEX®2-73 in Fragile X Syndrome • GlobeNewswire Inc. • 06/08/2022 11:00:00 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/27/2022 08:48:20 PM
H.C. Wainwright Reaffirms Their Buy Rating on Anavex Life Sciences (AVXL) • TipRanks • 05/20/2022 10:25:46 AM
Anavex Life Sciences to Present at the H. C. Wainwright Global Investment Conference 2022 • GlobeNewswire Inc. • 05/19/2022 11:00:00 AM
Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and OncoCyte (OCX) • TipRanks • 05/12/2022 07:39:47 AM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 Second Quarter Financial Results • GlobeNewswire Inc. • 05/10/2022 11:00:00 AM
Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tuesday May 10, 2022 • GlobeNewswire Inc. • 05/03/2022 11:00:00 AM
Anavex Life Sciences Announces Presentations at the IRSF Rett Syndrome Scientific Meeting • GlobeNewswire Inc. • 04/27/2022 11:00:00 AM
Anavex Life Sciences Invited to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference • GlobeNewswire Inc. • 04/26/2022 11:00:00 AM
The Next Catalyst Events at Trending Growth Companies and This Week's Feature Report • InvestorsHub NewsWire • 04/19/2022 12:30:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 04/11/2022 09:16:05 PM
Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 04/11/2022 09:09:24 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 04/08/2022 08:31:13 PM
Anavex Life Sciences to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2022 11:00:00 AM
Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit • GlobeNewswire Inc. • 03/28/2022 11:00:00 AM
H.C. Wainwright Thinks Anavex Life Sciences’ Stock is Going to Recover • TipRanks • 03/16/2022 10:19:26 AM

More AVXL News

InvestorsHub NewsWire

OTC: ILUS, ILUS International (Ilustrato Pictures International Inc.) Confirms the Settlement of Two $500,000 Notes and Announces a Further $5.6 Million in Funding • ILUS • Aug 8, 2022 1:49 PM

Progressive Care Announces Launch of New Logo as It Continues to Upgrade and Strengthen Its PharmcoRx Brand • RXMD • Aug 8, 2022 10:42 AM

Current Developments at Argentum 47, Inc. and Roadmap to 2023 • ARGQD • Aug 8, 2022 10:29 AM

Kona Gold Beverage, Inc Expands Sales Team • KGKG • Aug 8, 2022 9:00 AM

The Power of Science to Stop a Killer • NVS • Aug 8, 2022 8:45 AM

Mru Patel Appointed Non-Executive Director of Axis Technologies Group, Inc. • AXTG • Aug 5, 2022 9:00 AM

HealthLynked to Premier "Forever: The End of Aging" Medical Documentary atCMX CinéBistro Theater in Naples, Florida on August 28th • HLYK • Aug 5, 2022 8:00 AM

Progressive Care Announces Shareholder Conference Call and Business Update on August 11, 2022 • RXMD • Aug 5, 2022 7:15 AM

IGEN announces Net Profit for Second Quarter 2022 • IGEN • Aug 5, 2022 7:08 AM

Kaya Holdings to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in Oregon • KAYS • Aug 4, 2022 12:44 PM

American Rebel Holdings Completes Acquisition of Champion Safe Company, Solidifying A Leading Position in Safe Industry • AREBW • Aug 4, 2022 10:27 AM

OTC: ILUS, ILUS International (Ilustrato Pictures International Inc), Summarizes Its Second Quarter of 2022 Results, Including a 588% Revenue Increase Over the Same Period in 2021 • ILUS • Aug 4, 2022 10:19 AM

New Intranet- and Cloud-based Monitoring and Management Interface Enhances ResGreen's BotWay Software • RGGI • Aug 3, 2022 10:53 AM

Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics • TOMDF • Aug 3, 2022 9:48 AM

EV TECHNOLOGY GROUP ANNOUNCES AGREEMENT TO ACQUIRE UP TO 100% OF FABLINK GROUP, SPEARHEADING FUTURE GLOBAL GROWTH • EVTG • Aug 3, 2022 9:39 AM

Start posting your company's news
Only $200 per official company press release!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y

Detailed Quote

Follow Board

Keyboard Shortcuts

Report TOS Violation